Home News Coronavirus: AstraZeneca Defends EU Vaccine Rollout Plan

Coronavirus: AstraZeneca Defends EU Vaccine Rollout Plan

Coronavirus: AstraZeneca Defends EU Vaccine Rollout Plan
Coronavirus: AstraZeneca Defends EU Vaccine Rollout Plan

The head of AstraZeneca has defended its rollout of the coronavirus vaccine in the EU, amid tension with member states over delays in supply.

Pascal Soriot told the Italian newspaper La Repubblica that his team was working “24/7 to fix the very many issues of production of the vaccine”.

He said production was “basically two months behind where we wanted to be”.

He also said the EU’s late decision to sign contracts had given limited time to sort out hiccups with supply.

Mr. Soriot, chief executive of the UK-Swedish multinational, said a contract with the UK had been signed three months before the one with the EU, giving more time for glitches to be ironed out.

He told La Repubblica that problems in “scaling up” vaccine production were being experienced at two plants, one in the Netherlands and one in Belgium.

“It’s complicated, especially in the early phase where you have to really sort out all sorts of issues,” he said.

“We believe we’ve sorted out those issues, but we are basically two months behind where we wanted to be.”

He added: “We’ve also had teething issues like this in the UK supply chain. But the UK contract was signed three months before the European vaccine deal. So with the UK, we have had an extra three months to fix all the glitches we experienced.

“Would I like to do better? Of course. But, you know, if we deliver in February what we are planning to deliver, it’s not a small volume. We are planning to deliver millions of doses to Europe, it is not small.”

Mr. Soriot also said AstraZeneca was working on a vaccine with Oxford University that would target the South African variant of the coronavirus.

The AstraZeneca vaccine is already being used in the UK but has not yet been approved by the EU, although the European Medicines Agency (EMA) is expected to give it the green light at the end of this month.

The bloc signed a deal in August for 300 million doses, with an option for 100 million more. The EU had hoped that, as soon as approval was given, delivery would start straight away, with some 80 million doses arriving in the 27 nations by March.

The EU has ordered 600 million doses of the Pfizer-BioNTech vaccine, which is already being used on patients around the bloc.

But Pfizer-BioNTech said last week it was delaying shipments for the next few weeks because of work to increase capacity at its Belgian plant.

In response to the delays, the EU has said it might restrict exports of vaccines made in the bloc.

Health Commissioner Stella Kyriakides said companies making Covid vaccines in the bloc would have to “provide early notification whenever they want to export vaccines to third countries”.

She said the 27-member EU bloc would “take any action required to protect its citizens”.

European Commission President Ursula von der Leyen, addressing the virtual version of the annual World Economic Forum (WEF), usually held in Davos, said: “Europe invested billions to help develop the world’s first Covid-19 vaccines. And now, the companies must deliver. They must honour their obligations.”

 

Eskalera, a Startup Led by Goldman Sachs’ Former HR Head Has Launched a Diversity and Inclusion Index

Eskalera, a technology startup led by Goldman Sachs former human resources head Dane Holmes, has launched an index to measure corporate diversity and inclusiveness,...

HSBC to Remove 35,000 Jobs Amidst Covid-19 Crises

HSBC Holdings Plc has restarted cutting as many as 35,000 jobs, three months after the coronavirus outbreak forced it to pause a long-awaited overhaul...

Genpact Offers Its Internal Skill Training Program Globally for Everyone

Genpact has announced Adapt and Rise, a role-based online learning platform that leverages Genpact's expertise honed from delivering real-world change for hundreds of clients....

San-Francisco Based Learning Platform Degreed Has Raised $32 Million in New Funding

The upskilling platform, Degreed, has announced $32 million in new funding in direct response to overwhelming demand for better skill insights, talent mobility, and...

Research Shows the Implications of Workplace Layouts on Employee Productivity and Overall Performance

As some workplaces prepare for the gradual return of employees and overhaul office layouts and seating plans, research has shown this could also have...

Employee Concierge ‘Back Technologies’ Integrates Automation Into Internal HR and Other Support Tasks

Companies are under increasing pressure to automate workflows and digitally service their employees, particularly in light of trends toward remote work. It takes an...

HR Strategies to Help Your Business Navigate the New ‘Normal’

No business is immune to the massive changes resulting from the health crisis. Organizations have proven themselves to be agile, and employees have demonstrated...

The Importance Of Diversity And Inclusion In HR, Hiring, Talent Management: Thoughts From A Top Expert

Michael C. Hyter is one of today’s best-known experts on inclusion and diversity and the author of The Power of Choice: Embracing Efficacy to Drive Your Career and The...

HR Expert Highlights Actionable Steps to ‘Make Real Change’ Against Racism in Your Workplace

Kyra Leigh Sutton, Ph.D., is a faculty member at the Rutgers University School of Management and Labor Relations, where she teaches human resources courses...

Adidas Employees Want Company to Investigate HR Chief for Response to Racial Issues

A group of Adidas employees from around the globe is asking the company to investigate its chief human resources officer, as part of a...